Rigel Pharmaceuticals, Inc. (RIGL) short interest & options flow
NASDAQRigel Pharmaceuticals heads into the summer with a notable contradiction at its core: short sellers are pushing back in, yet the Street just raised its most bullish price targets in months. Short interest has climbed back to its highest level in over six weeks. At 26.7% of the free float, it has recovered from a dip to 24.6% in mid-May and is now matching the late-April peak. The…
- Market cap
- $838M
- Next earnings
- 2 Mar 2027
Key data as of 12 Nov 2026

RIGL news and analysis
RSSNo long-form analysis yet for RIGL. Pulse alerts and the live data picture are available on ORTEX.
Open RIGL on ORTEX →Want the live picture for RIGL?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RIGL — free to start on ORTEX.
Sign up for free →Open RIGL on ORTEX